Cd19-selective t cell engaging molecule for treating autoimmune diseases / autoimmune conditions
APP2026017468A0Pending Publication Date: 2026-07-31AMGEN RESEARCH (MUNICH) GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- AP2026017468
- Authority / Receiving Office
- AP · AP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-02-27
- Publication Date
- 2026-07-31
Need to check novelty before this filing date? Find Prior Art
No text content released.